Safety and immunogenicity of different booster vaccination schemes for COVID-19 used in El Salvador.

Xochitl Sandoval Rhina Domínguez Delmy Lisseth Recinos Susana Zelaya Patricia Cativo Guillermo Horacio Docena

Published in: Clinical and experimental vaccine research (2024)

These findings indicate that the booster doses used were safe and promoted an immediate increase in immunogenicity, which decreased over time. The heterologous regimen showed stronger immunogenicity compared to the messenger RNA-based homologous scheme.

Keyphrases

coronavirus disease
sars cov
dna damage
dna repair
saccharomyces cerevisiae
respiratory syndrome coronavirus